Trending Now
LeafDraft — daily expert insights on technology, finance & world news
540
Articles published
11
Topics covered
90.3K
Articles read

How Ozempic and Mounjaro Affect Your Brain: What Science Shows
Newer diabetes and weight-loss drugs such as semaglutide (Ozempic) and tirzepatide (Mounjaro) influence appetite and metabolism — and growing evidence suggests they also change brain circuits that control hunger, reward, mood and cognition. Understanding those brain effects can help patients and clinicians weigh benefits and risks.

19-Year Study Links Long Naps to Higher Mortality Risk
A 19-year cohort study found a correlation between prolonged daytime naps and an increased risk of mortality. This feature unpacks the research, explores plausible biological and behavioral explanations, and offers practical guidance for safer daytime rest.

AI Discovers Natural Ozempic Alternative With Fewer Side Effects
Researchers using artificial intelligence have identified a promising natural compound that may mimic semaglutide’s weight-loss and glucose-control effects while reducing common gastrointestinal side effects. Early data are preclinical and suggest a cautious optimism pending human trials and regulatory review.

AI Finds Hidden Heart Signal Predicting Sudden Cardiac Death
Researchers using machine learning have identified a subtle, previously overlooked cardiac signal that may forecast sudden cardiac death. If validated and safely integrated into care, the finding could transform screening, monitoring, and preventive treatment for at-risk patients.

Colorectal Cancer Is Rising Again: What Scientists Still Don't Know
After two decades of declines, colorectal cancer rates have begun to climb again in several countries. Researchers are confronting unsettling patterns — younger patients, shifting tumor biology, and no single clear cause — even as clinicians emphasize screening and prevention.

Osteoporosis Drugs Linked to 24% Lower Dementia Risk — What It Means
A major new study found that commonly prescribed osteoporosis medications were associated with a 24% lower risk of developing dementia. This article explains the study’s findings, plausible biological mechanisms, limitations, and practical guidance for patients and clinicians.